Val34Leu factor XIII polymorphism in Italian patients with inflammatory bowel disease

Digestive and Liver Disease

Volumn 35, Issue 1, 2003, Pages 32-36

  Saibeni, S ^a   Vecchi, M ^a   Faioni, E M ^a   Franchi, F ^a   Rondonotti, E ^a   Borsi, G ^a   de Franchis, R ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Coagulation; Factor XIII; Inflammatory bowel disease

Indexed keywords

BLOOD CLOTTING FACTOR 13; FIBRIN; LEUCINE; VALINE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; FISHER EXACT TEST; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; STATISTICAL ANALYSIS; THROMBOSIS; ULCERATIVE COLITIS; WOUND HEALING;

EID: 0038069034     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(02)00008-7     Document Type: Article

References (33)

1. Bargen JA, Barker NW. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Int Med 1936;58:17-31.
2. Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Rowles PM, Lewis AM, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989;2:1057-62.
3. Hamilton MI, Dick R, Crawford L, Thompson NP, Pounder RE, Wakefield AJ. Is proximal demarcation of ulcerative colitis determined by the territory of the inferior mesenteric artery? Lancet 1995;345:688-90.
4. Stadnicki A, Kloczko J, Nowak A, Sierka E, Sliwinski Z. Factor XIII subunits in relation to some other haemostatic parameters in ulcerative colitis. Am J Gastroenterol 1991;86:690-5.
5. Hudson M, Wakefield AJ, Hutton RA, Stankey EA, Dhillon AP, More L, et al. Factor XIIIA subunit and Crohn's disease. Gut 1993;34:35-9.
6. Chamouard P, Grunebaum L, Wiesel ML, Sibilia J, Coumaros G, Wittersheim C, et al. Significance of diminished factor XIII in Crohn's disease. Am J Gastroenterol 1998;93:610-4.
7. Lorenz R, Olbert P, Born P. Factor XIII in chronic inflammatory bowel disease. Sem Thromb Hemost 1996;22:451-5.
8. Oshitani N, Kitano A, Hara J, Suzuki N, Aoki T, Yasuda K, et al. Deficiency of blood coagulation Factor XIII in Crohn's disease. Am J Gastroenterol 1995;90:1116-8.
9. van Bodegraven AA, Tuynman HARE, Schoorl M, Kruishoop AM, Bartles PCM. Fibrinolytic split products, fibrinolysis and Factor XIII activity in inflammatory bowel disease. Scand J Gastroenterol 1995;30:580-5.
10. Stadnicki A, Kloczko J, Nowak A, Sierka E. Alterations of haemostasis parameters with special reference to Factor XIII and fibronectin in patients with ulcerative colitis. Eur J Gastroenterol Hepatol 1992;4:743-6.
11. Greenberg CS. Fibrin formation and stabilization. In: Loscalzo J, Schafer AI, editors, Thrombosis and haemorrhage, Boston: Blackwell Scientific Publications, 1994, pp. 107-26.
12. Lorenz R, Born P, Olbert P, Classen M. Factor XIII substitution in ulcerative colitis. Lancet 1995;345:449-50.
13. Oshitani N, Nakamura S, Matsumoto T, Kobayashi K, Kitano A. Treatment of Crohn's disease fistulas with coagulation Factor XIII. Lancet 1996;347:119-20.
14. Bregenzer N, Caesar I, Andus T, Hamling J, Malchow H, Schreiber S, et al. Lack of clinical efficacy of additional Factor XIII treatment in patient with steroid refractory colitis. The Factor XIII Study Group. Z Gastroenterol 1999;37:999-1004.
15. Mikkola H, Syrjala M, Rasi V, Vahtera E, Peltonen L, Palotia A. Deficiency in the A-subunit of coagulation Factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood 1994;84:517-25.
16. Catto AJ, Kohler HP, Coore J, Mansfield MW, Stickland MH, Grant PJ. Association of a common polymorphism in the Factor XIII gene with venous thrombosis. Blood 1999;93:906-8.
17. Franco RF, Reitsma PH, Lourenco D, Maffei MH, Morelli V, Tavella MH, et al. Factor XIII Val34Leu is a genetic factor involved in the aetiology of venous thrombosis. Thromb Haemost 1999;81:676-9.
18. Kohler HP, Stickland MH, Ossei-Gerning N, Carter A, Mikkola H, Grant PJ. Association of a common polymorphism in the Factor XIII gene with myocardial infarction. Thromb Haemost 1998;79:8-13.
19. Wartiovaara U, Perola M, Mikkola H, Totterman K, Savolainen V, Penttila A, et al. Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis 1999;142:295-300.
20. Zoghbi HY, Daiger SP, McCall A, O'Brien WE, Beaudet AL. Extensive DNA polymorphism at the Factor XIIIa (F13A) locus and linkage to HLA. Am J Hum Genet 1988;42:877-83.
21. Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, Mascheretti S, et al. Linkage of inflammatory bowel disease to human chromosome 6. Am J Hum Genet 1999;65:1647-55.
22. Gasche C, Schölmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000;6:8-15.
23. Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human mutated cells. Nucleic Acid Res 1988;16:1215-8.
24. Corral J, Gonzales-Conejero R, Iniesta JA, Rivera J, Martinez C, Vicente V. The Factor XIII Val34Leu polymorphism venous and arterial thromboembolism. Haematologica 2000;85:293-7.
25. Muszbek L. Deficiency causing mutation and common polymorphisms in the Factor XIII-A gene. Thromb Haemost 2000;84:524-7.
26. Ariens RAS, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. The Factor XIII V34L polymorphism accelerates thrombin activation of Factor XIII and affects cross-linked structure. Blood 2000;96:988-95.
27. Vecchi M, Sacchi E, Saibeni S, Meucci G, Tagliabue L, Duca F, et al. Inflammatory bowel disease are not associated with major hereditary conditions predisposing to thrombosis. Dig Dis Sci 2000;45:1465-9.
28. Turri D, Rosselli M, Simioni P, Tormene D, Grimaudo S, Martorana G, et al. Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean area. Digest Liver Dis 2001;33:559-62.
29. Helio T, Wartiovaara U, Halme L, Turunen M, Mikkola H, Palotie A, et al. Arg506Gln Factor V mutation and Val34Leu Factor XIII polymorphism in Finnish patients with Inflammatory Bowel Diseases. Scand J Gastroenterol 1999;34:170-4.
30. Hayat M, Ariens RA, Moayyedi P, Grant PJ, O'Mahony S. Coagulation Factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002;14:249-56.
31. Faioni EM, Franchi F, Bucciarelli P, Margaglione M, De Stefano V, Castaman G, et al. Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (Factor V Leiden). Blood 1999;94:3062-6.
32. Saibeni S, Vecchi M, Valsecchi C, Faioni EM, Razzari C, de Franchis R. Reduced free protein S levels in patients with inflammatory bowel disease. Prevalence, clinical relevance and role of anti-protein S antibodies. Dig Dis Sci 2001;46:637-43.
33. Cattaneo M, Vecchi M, Zighetti ML, Saibeni S, Martinelli I, Omodei P, et al. High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications? Thromb Haemost 1998;80:542-5.